l1sL1s
Injective Protocol
Injective Protocol

Injective Protocol

Description

Injective Protocol is a pioneering DeFi platform known for its decentralized exchange supporting spot, futures, and perpetual markets with no gas fees. It leverages a unique layer-2 blockchain solution, offering high speed, instant finality, and front-running resistance tailored for financial applications. Users can create and trade on derivative markets using only a price feed and decentralized order book, powered by the Injective Chain and Ethereum's EVM. The native token, INJ, facilitates governance, liquidity mining, and staking. INJ operates on Ethereum with a fixed supply of 100 million tokens, traded actively in multiple markets. The dynamic pricing of INJ reflects its volatile trading nature. The protocol empowers decentralized trading and governance, enhancing accessibility, security, and efficiency in blockchain finance. Users are encouraged to visit [Injective's website](https://injective.com) for more details.

Injective Protocol is a pioneering DeFi platform known for its decentralized exchange supporting spot, futures, and perpetual markets with no gas fees. It leverages a unique layer-2 blockchain solution, offering high speed, instant finality, and front-running resistance tailored for financial applications. Users can create and trade on derivative markets using only a price feed and decentralized order book, powered by the Injective Chain and Ethereum's EVM. The native token, INJ, facilitates governance, liquidity mining, and staking. INJ operates on Ethereum with a fixed supply of 100 million tokens, traded actively in multiple markets. The dynamic pricing of INJ reflects its volatile trading nature. The protocol empowers decentralized trading and governance, enhancing accessibility, security, and efficiency in blockchain finance. Users are encouraged to visit [Injective's website](https://injective.com) for more details.

Socials

https://twitter.com/Injective_
https://github.com/InjectiveLabs

FAQ

Company is unclaimed. Do you work for or own this company?